TABLE-Immuno Biological Lab <4570.OS>-6mth parent

   Oct 29 (Reuters) -

                IMMUNO BIOLOGICAL LABORATORIES CO LTD

                PARENT-ONLY FINANCIAL HIGHLIGHTS

 (in billions of yen unless specified)

            6 months ended  6 months ended  Full year to    Full year ended

               Sep 30, 2010    Sep 30, 2009    Mar 31, 2011    Mar 31, 2010

               LATEST          YEAR-AGO        COMPANY         YEAR-AGO  

               H1 RESULTS      H1 RESULTS      FORECAST        RESULTS   
 Sales                498 mln         448 mln        1.02                   

                (+11.1 pct)     (-14.7 pct)         (-3.7%)              
 Operating       loss 119 mln    loss 173 mln    loss 160 mln               
 Recurring       loss 114 mln    loss 171 mln    loss 155 mln               
 Net             loss 121 mln    loss 171 mln    loss 195 mln               
 EPS             loss Y196.52    loss Y277.77    loss Y316.36               
 Shares           616,400         616,400                                   
 Annual div                                                nil             nil
  -Q2 div                  nil             nil                              
  -Q4 div                                  nil             nil              

 NOTE - Immuno Biological Laboratories Co Ltd is the full company name.

 If there is no Q1 or Q3 dividend, Q2 will in most cases
correspond to the first-half dividend and Q4 to the second-half
dividend announced before a new corporate law in 2006 allowed
companies to pay and report dividends on a quarterly basis.

 For latest earnings estimates made by Toyo Keizai, please
double click on 4570.TK1.